6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Opiate Replacement Therapy in Addiction Treatment
Opiate Replacement Therapy (ORT) is a medical approach used to treat opioid addiction by substituting a long-acting, less harmful opioid for the opioid that the individual is addicted to. Commonly, methadone and buprenorphine are used in this therapy. ORT helps in reducing withdrawal symptoms, cravings, and the risk of overdose. This treatment is typically combined with counseling and other supportive therapies to address the psychological aspects of addiction. ORT has shown significant success in improving patient retention in addiction treatment programs and enhancing long-term recovery outcomes. It's considered a crucial part of harm reduction strategies, aiming to stabilize patients and improve their quality of life while they work towards recovery.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Jana Furstova
Palacký University Olomouc, Czech Republic
Alexander Kharibegashvil
Telavi State University, GeorgiaSubmit your abstract Today
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrative addiction and mental health wellness lecture
John Giordano, Life Enhancement Recovery Center, United States
Title : Step one therapy
Ashton Christopher, Center for Recovery, Canada
Title : Addiction rehabilitation & recovery: Pathways to healing and resilience
Sindu Padmanabhan, Bharathiar University, India
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States